Your browser doesn't support javascript.
loading
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.
Desai, Milind Y; Owens, Anjali; Geske, Jeffrey B; Wolski, Kathy; Naidu, Srihari S; Smedira, Nicholas G; Cremer, Paul C; Schaff, Hartzell; McErlean, Ellen; Sewell, Christina; Li, Wanying; Sterling, Lulu; Lampl, Kathy; Edelberg, Jay M; Sehnert, Amy J; Nissen, Steven E.
Afiliación
  • Desai MY; Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, Ohio, USA; Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart, Vascular & Thoracic Institute, C
  • Owens A; Division of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Geske JB; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • Wolski K; Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Naidu SS; Department of Cardiology, Westchester Medical Center, Valhalla, New York, USA.
  • Smedira NG; Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, Ohio, USA; Department of Cardiothoracic Surgery, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Cremer PC; Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Schaff H; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • McErlean E; Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Sewell C; Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Li W; MyoKardia, Inc, a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, California, USA.
  • Sterling L; MyoKardia, Inc, a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, California, USA.
  • Lampl K; MyoKardia, Inc, a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, California, USA.
  • Edelberg JM; MyoKardia, Inc, a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, California, USA.
  • Sehnert AJ; MyoKardia, Inc, a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, California, USA.
  • Nissen SE; Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: nissens@ccf.org.
J Am Coll Cardiol ; 80(2): 95-108, 2022 07 12.
Article en En | MEDLINE | ID: mdl-35798455

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Miosinas Tipo de estudio: Clinical_trials / Guideline Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Miosinas Tipo de estudio: Clinical_trials / Guideline Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos